The challenges
- Continued pressure on the price of medicines.
- Higher regulatory hurdles for new medicines and new indications.
- Competition from research-based and, increasingly, generic pharmaceutical companies.
QUICK LINKS
DOWNLOAD REPORT
Our report is available to download in CORPORATE RESPONSIBILITY
Find out more about our commitment to responsible business
GLOSSARY
Abbreviations/expressions and their meanings, when used on this website
FEEDBACK
Your opinions and comments are very important to us
